Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers.

about

Epigenetics in endometrial carcinogenesis - part 1: DNA methylation.Recent findings on epigenetic gene abnormalities involved in uterine cancer.

P2860

Q39282288-FA7CDE05-F2A9-4C23-91A2-E2BB956355B2 Q47153989-C41231B0-7069-4E48-8865-06634210CB86

P2860

Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers.

Item

http://www.wikidata.org/entity/Q38630962

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers.

@en

type

Item

label

Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers.

@en

prefLabel

Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers.

@en

P1476

Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers.

@en

P2093

Alfonso Duenas-Gonzalez

http://www.w3.org/2001/XMLSchema#string

Alma Chavez-Blanco

http://www.w3.org/2001/XMLSchema#string

Eli Fernández-de Gortari

http://www.w3.org/2001/XMLSchema#string

Guadalupe Dominguez-Gomez

http://www.w3.org/2001/XMLSchema#string

José L Medina-Franco

http://www.w3.org/2001/XMLSchema#string

P2860

DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets

Activation-induced cytidine deaminase auto-activates and triggers aberrant gene expression

A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands

An operational definition of epigenetics

Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine

The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome

Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer

Reprogramming DNA methylation in the mammalian life cycle: building and breaking epigenetic barriers

P304

323-338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2016.1118053

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26559668

http://www.w3.org/2001/XMLSchema#string

Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers.

about

P2860

P2860

Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698